Overview

Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
0
Participant gender:
All
Summary
Objectives. The investigators analysed the effects of tight glycemic control in regenerative potential of the myocardium during acute myocardial infarction (AMI). Background. A strict glycemic control after AMI improves the cardiac outcome. The role of tight glycemic control in regenerative potential of the myocardium during acute myocardial ischemia are still largely unknown. Methods. Sixty-five patients with first AMI undergoing coronary bypass surgery were studied: 25 normoglycemic patients served as control group; hyperglycemic patients (glucose >140 mg/dl) were randomized to intensive glycemic control (IGC, n=20; glucose goal 80-140 mg/dl) or conventional glycemic control (CGC, n=20; glucose goal180-200 mg/dl) for almost 3 days before surgery, using insulin infusion followed by subcutaneous insulin treatment. Echocardiographic parameters were investigated at admission and after treatment period. During surgery, oxidative stress (nitrotyrosine, O2- production), apoptosis (Caspase-3) and cardiac stem cells (CSCs) (c-kit, MDR1 and Sca-1 positive cells) were analysed in biopsy specimens taken from the peri-infarcted area.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Second University of Naples
University of Campania "Luigi Vanvitelli"
Treatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- evidence of AMI within the last 8 h (troponin-I >2.50 µg/l together with either
typical symptoms of angina or electrographic criteria of ST-segment modification)

- first uncomplicated AMI

- the need for CABG

Exclusion Criteria:

- previous AMI

- inflammatory disorders

- malignancy

- renal diseases infections